Related Experiment Video
Updated: Jul 14, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against
Annapoorani Chockalingam1, Cindy E McKinney, Manuela Rinaldi
1Department of Dairy and Animal Science, Pennsylvania State University, University Park, PA 16802, USA.
Abstract:
Gram-negative bacteria are responsible for approximately one-third of the clinical cases of bovine mastitis and can elicit a life-threatening, systemic inflammatory response. Lipopolysaccharide (LPS) is a membrane component of Gram-negative bacteria and is largely responsible for evoking the inflammatory response. Antibiotic and anti-inflammatory therapy for treating Gram-negative infections remains suboptimal. Bactericidal/permeability-increasing protein (BPI) is a neutrophil-derived protein with antimicrobial and LPS-neutralizing properties. Select peptide derivatives of BPI are reported to retain these properties. The objective of this study was to evaluate the antimicrobial activity of a human BPI-derived synthetic peptide against clinical bovine mastitis isolates of Gram-negative bacteria. A hybrid peptide was synthesized corresponding to two regions of human BPI (amino acids 90-99 and 148-161), the former of which has bactericidal activity and the latter of which has LPS-neutralizing activity. The minimum inhibitory (MIC) and bactericidal (MBC) concentrations of this peptide against various genera of bacteria were determined using a broth microdilution assay. The MIC's were determined to be: 16-64 microg/ml against Escherichia coli; 32-128 microg/ml against Klebsiella pneumoniae and Enterobacter spp.; and 64-256 microg/ml against Pseudomonas aeruginosa. The MBC's were equivalent to or 1-fold greater than corresponding MIC's. The peptide had no growth inhibitory effect on Serratia marcescens. The antimicrobial activity of the peptide was retained in the presence of serum, but severely impaired in milk. Further functional evaluation of the peptide demonstrated its ability to completely neutralize LPS. Together, these data support additional investigations into the therapeutic application of BPI to the treatment of Gram-negative infections in cattle.
Insights
A novel synthetic peptide derived from human Bactericidal/permeability-increasing protein (BPI) shows antimicrobial activity against Gram-negative bacteria causing bovine mastitis. This peptide effectively neutralizes lipopolysaccharide (LPS), offering potential for new cattle infection treatments.
Area of Science:
- Veterinary Medicine
- Microbiology
- Biochemistry
Background:
- Gram-negative bacteria cause significant bovine mastitis cases, leading to severe systemic inflammation due to lipopolysaccharide (LPS).
- Current treatments for Gram-negative infections and associated inflammation in cattle are suboptimal.
- Bactericidal/permeability-increasing protein (BPI) is a human neutrophil protein with known antimicrobial and LPS-neutralizing capabilities.
Purpose of the Study:
- To assess the antimicrobial efficacy of a synthetic peptide derived from human BPI against Gram-negative bacteria implicated in bovine mastitis.
- To evaluate the peptide's ability to neutralize LPS and its activity in the presence of bovine serum and milk.
Main Methods:
- A hybrid synthetic peptide combining bactericidal (amino acids 90-99) and LPS-neutralizing (amino acids 148-161) regions of human BPI was synthesized.
- Broth microdilution assays were used to determine the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) against clinical isolates.
- Functional assays assessed LPS neutralization and peptide activity in serum and milk.
Main Results:
- The peptide exhibited antimicrobial activity against Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and Pseudomonas aeruginosa, with MICs ranging from 16-256 µg/ml.
- MBCs were comparable to MICs, indicating bactericidal action, though no effect was observed against Serratia marcescens.
- The peptide retained activity in serum but was significantly impaired in milk, yet it completely neutralized LPS.
Conclusions:
- The BPI-derived peptide demonstrates significant antimicrobial and LPS-neutralizing properties against key Gram-negative mastitis pathogens.
- Its efficacy in serum but not milk suggests potential challenges for intramammary application, warranting further investigation.
- These findings support the exploration of BPI-based therapeutics for treating Gram-negative infections in cattle.
More Related Videos
06:05Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
10:13Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
Published on: August 11, 2018
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanism of Antibiotic Resistance in MRSA
Biological Methods for Microbial Control
Bacterial Meningitis